When Martin Predicts a "10-Bagger," You Should Listen

    Text size
The last time we wrote about baby biotech Galapagos NV (PINK ADR: GLPYY), the Private Briefing column featured the headline: "On This Stock, the Good News Just Keeps Coming." Today's follow-up column could feature the very same headline. That's because knowledgeable outsiders (including Johnson & Johnson Inc. (NYSE: JNJ), this time around) keep buying big […]